Inogen Inc Stock Analysis

Inogen Stock Analysis Notes

About 81.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.14. Some equities with similar Price to Book (P/B) outperform the market in the long run. Inogen Inc recorded a loss per share of 1.52. The entity had not issued any dividends in recent years. Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. Inogen operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1021 people. To learn more about Inogen Inc call Nabil Shabshab at 805 562 0500 or check out https://provider.inogen.com/en.

Inogen Inc Investment Alerts

Inogen Inc Upcoming and Recent Events

Inogen Largest EPS Surprises

View All Earnings Estimates

Inogen Environmental, Social, and Governance (ESG) Scores

Inogen Thematic Classifications

Inogen Stock Institutional Investors

Note, although Inogen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Inogen Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 198.44 M.

Inogen Profitablity

The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.13) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.13.

Management Efficiency

Inogen Inc has return on total asset (ROA) of (0.0778) % which means that it has lost $0.0778 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1896) %, meaning that it created substantial loss on money invested by shareholders. Inogen's management efficiency ratios could be used to measure how well Inogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 20th of March 2025, Return On Tangible Assets is likely to grow to -0.13. In addition to that, Return On Capital Employed is likely to grow to -0.18. At this time, Inogen's Non Currrent Assets Other are very stable compared to the past year. As of the 20th of March 2025, Total Current Assets is likely to grow to about 204.8 M, while Total Assets are likely to drop about 294.4 M.

Technical Drivers

As of the 20th of March, Inogen retains the Risk Adjusted Performance of (0.06), market risk adjusted performance of (0.20), and Standard Deviation of 3.82. Inogen technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Inogen Inc Price Movement Analysis

Inogen Inc Insider Trading Activities

Inogen Outstanding Bonds

Inogen Predictive Daily Indicators

Inogen Corporate Filings

Inogen Forecast Models

Inogen's time-series forecasting models are one of many Inogen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Inogen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Inogen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Inogen. By using and applying Inogen Stock analysis, traders can create a robust methodology for identifying Inogen entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Inogen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Inogen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Inogen Inc stock analysis indicators help investors evaluate how Inogen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Inogen shares will generate the highest return on investment. By understating and applying Inogen stock analysis, traders can identify Inogen position entry and exit signals to maximize returns.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.